MAPT and Alzheimer disease: FKBP51 plays a dual role in Alzheimer’s disease pathogenesis: on one hand, it stabilizes tau and facilitates its toxic oligomerization through an HSP90-dependent mechanism; conversely, when forming a complex with p23, it may exert a protective function via an HSP90-independent pathway.